TransCode begins patient dosing in Cohort 4 of phase 1 trial with TTX-MC138 to treat metastatic cancer: Boston Monday, March 31, 2025, 18:00 Hrs [IST] TransCode Therapeutics, Inc.

BridgeBio Pharma’s Beyonttra to treat transthyretin-mediated amyloid cardiomyopathy receives Japanese approval: Palo Alto, California Monday, March 31, 2025, 17:00 Hrs [IST] Bri ...

Artificial intelligence could help identify abnormalities in unborn babies quicker: United Kingdom Monday, March 31, 2025, 16:00 Hrs [IST] A first of its kind study has found arti ...

UK MHRA approves trofolastat for diagnostic imaging of prostate cancer in men: United Kingdom Monday, March 31, 2025, 15:00 Hrs [IST] The Medicines and Healthcare products Regulat ...

An artificial intelligence (AI) tool has shown to speed up diagnosis for people with coeliac disease. The study published in the New England Journal of Medicine, shows how the AI tool can process ...

Novartis radioligand therapy, Pluvicto gets US FDA approval for earlier use before chemotherapy in PSMA-positive mCRPC: Basel Monday, March 31, 2025, 13:00 Hrs [IST] Novartis anno ...

SPARC seeks US FDA nod to start phase 1 trial of SBO-154 to treat advanced solid tumours: Our Bureau, Mumbai Monday, March 31, 2025, 12:15 Hrs [IST] Sun Pharma Advanced Research C ...

Ultromics introduces AI-powered probability scoring on EchoGo Heart Failure for enhanced HFpEF diagnosis: Oxford, England Monday, March 31, 2025, 12:00 Hrs [IST] Ultromics, a pion ...

EMA committee recommends approval of Bristol Myers Squibb’s subcutaneous formulation of Opdivo across multiple solid tumour indications: Princeton, New Jersey Monday, March 31, ...

Silver Spring, Maryland Monday, March 31, 2025, 09:00 Hrs [IST] ...

All DIs in TN are fully competent to inspect manufacturing units as per Revised Schedule M: MN Sridhar: Monday, March 31, ...

DCO India suggests ways to improve functioning of Manipur drug control administration: Peethaambaran Kunnathoor, Chennai ...